Strong Buy Rating for Amgen Amidst Impressive Growth and …

Oct 30, 2024  · These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks , Werber is a 5-star analyst with an average return of 14.0% and a 57.14% success rate.


Install CouponFollow Chrome Extension   CouponFollow Extension

0%
OFF

Strong Buy Rating For Amgen Amidst Impressive Growth And …

2 weeks from now

Oct 30, 2024  · These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks , Werber is a 5-star analyst with an average return of 14.0% and a 57.14% success rate.

businessinsider.com

25%
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

The company's strong performance is reflected in its 21.25% revenue growth over the last twelve months. According to Erste Group analysts, Amgen is expected to maintain an upward …

msn.com

$381
OFF

Amgen Inc. (AMGN) Analyst Ratings - Stock Analysis

2 weeks from now

Jan 31, 2025  · A list of analyst ratings for Amgen (AMGN) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... Strong Buy. Maintains. $381 → …

stockanalysis.com

$383.00
OFF

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024  · TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00. ... Amgen’s Growth Potential …

businessinsider.com

$380.00
OFF

What Analysts Are Saying About Amgen Stock | Nasdaq

2 weeks from now

Nov 14, 2024  · Analysts' ratings for Amgen (NASDAQ: ... Buy: $380.00: $380.00: Colin Bristow: UBS: Lowers: Neutral: ... Revenue Growth: Amgen's revenue growth over a period of 3 …

nasdaq.com

$383
OFF

Amgen Shares Keep Buy Rating As Analyst Updates Model Ahead Of …

2 weeks from now

Oct 21, 2024  · On Monday, TD Cowen maintained a Buy rating on Amgen (NASDAQ: AMGN) and slightly raised the price target to $383 from $381.The adjustment reflects an updated valuation …

investing.com

81%
OFF

Amgen Recognized As A Top Growth Stock With Strong Ratings …

2 weeks from now

Nov 10, 2024  · Amgen Inc. is making waves in the biotechnology sector with an impressive 81% rating from Validea's Multi-Factor Investor model, showcasing its low volatility and strong …

folikoinsights.com

$370.00
OFF

Goldman Sachs Backs Amgen Shares With Buy Rating, Emphasizing …

2 weeks from now

Jan 8, 2025  · On Wednesday, Goldman Sachs reaffirmed its Buy rating and $370.00 price target for Amgen (NASDAQ: AMGN) shares. The firm's analyst, Salveen Richter, provided insights …

investing.com

81%
OFF

Amgen Receives Strong Investment Ratings Amid Market …

2 weeks from now

Nov 7, 2024  · Amgen Inc. is capturing investor attention with an impressive 81% rating from Validea's Multi-Factor Investor model, signaling strong fundamentals and growth potential. In a …

folikoinsights.com

$362.00
OFF

Amgen’s Strategic Shift And Strong Pipeline Drive Buy Rating

2 weeks from now

Jan 14, 2025  · Analyst Evan Seigerman of BMO Capital maintained a Buy rating on Amgen (AMGN – Research Report), retaining the price target of $362.00. Discover outperforming …

businessinsider.com

05%
OFF

2 Reasons To Buy Amgen Stock, And 1 Reason To Be Cautious

2 weeks from now

Nov 16, 2024  · While Amgen's (AMGN 0.05%) shares have underperformed the market over the past 12 months, climbing 19.7% compared to the market's unusually large gain of 35.6%, …

fool.com

$370
OFF

Erste Group Lifts Amgen Stock Rating To Buy On Strong Margins

2 weeks from now

2 days ago  · Lastly, Goldman Sachs maintained its Buy rating on Amgen stock with a price target of $370, following discussions with Amgen's management about the company's late-stage …

investing.com

13%
OFF

Is Amgen Stock A Buy? - Nasdaq

2 weeks from now

Oct 18, 2024  · Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months. Despite a string of solid earnings reports from …

nasdaq.com

$370.00
OFF

Goldman Sachs Retains Amgen Buy Stock Rating On Clinical Trial

2 weeks from now

Jan 15, 2025  · On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ:AMGN), maintaining a price target of $370.00. The biotechnology giant, with a …

investing.com

87%
OFF

Amgen Receives Strong Ratings From Validea's Multi-Factor …

2 weeks from now

Oct 15, 2024  · Amgen Inc. has achieved an impressive 87% rating from Validea's Multi-Factor Investor model, highlighting its strong fundamentals and growth potential in the Biotechnology …

folikoinsights.com

$295
OFF

Are Wall Street Analysts Predicting Amgen Stock Will Climb Or Sink?

2 weeks from now

3 days ago  · On Jan. 28, Citi lowered its price target on Amgen to $295, maintaining a “Neutral” rating due to a more challenging biotech sector outlook in 2025. As of writing, AMGN is trading …

nasdaq.com

FAQs about Strong Buy Rating for Amgen Amidst Impressive Growth and … Coupon?

Should you buy Amgen (Amgen) stock?

These factors combined present a strong case for the Buy rating on Amgen’s stock. According to TipRanks, Werber is a 5-star analyst with an average return of 14.0% and a 57.14% success rate. Werber covers the Healthcare sector, focusing on stocks such as Amgen, BioNTech SE, and Exelixis. ...

Why has Yaron Werber rated Amgen (Amgen) a buy?

Yaron Werber has given his Buy rating due to a combination of factors that indicate strong future growth for Amgen. The company’s performance in the third quarter was impressive, with earnings per share exceeding expectations due to reduced operational expenses and tax rates. ...

Why has Nico Chen rated Amgen (Amgen) a buy?

Nico Chen has given his Buy rating due to a combination of factors including Amgen’s consistent performance in launching blockbuster drugs and positive clinical trial data, as well as strategic mergers and acquisitions. Amgen’s track record since 2018 indicates that such events have historically led to significant share price increases. ...

Is Amgen Inc (AMGN) undervalued?

Valuation metrics show that Amgen Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AMGN, demonstrate its potential to outperform the market. It currently has a Growth Score of C. ...

Is Amgen (Amgen) overvalued?

The two-model average is ~$299.37, indicating that Amgen is overvalued at the current price. However, Wall Street analysts are somewhat less bullish, with an average price target of $313.66, 2.5% higher than the current value and more than our two-model average. ...

Why did Erste Group Upgrade Amgen shares from hold to buy?

On Wednesday, Erste Group upgraded shares of biotechnology firm Amgen (NASDAQ:AMGN) from Hold to Buy. The upgrade was primarily attributed to Amgen's financial performance, which includes a higher operating margin and impressive 56% return on equity. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension